James R. Largent's most recent trade in Alimera Sciences Inc. was a trade of 6,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 4, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Alimera Sciences Inc. | James R. Largent | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2023 | 6,000 | 6,000 | - | - | Stock Option (Right to Buy) | |
Alimera Sciences Inc. | James R. Largent | Director | Purchase of securities on an exchange or from another person at price $ 4.31 per share. | 02 Nov 2021 | 10,000 | 13,000 (0%) | 0% | 4.3 | 43,090 | Common Stock |
Alimera Sciences Inc. | James R. Largent | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2021 | 6,000 | 6,000 | - | - | Stock Option (Right to Buy) | |
Alimera Sciences Inc. | James R. Largent | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2020 | 3,333 | 3,333 | - | - | Stock Option (Right to Buy) |